Sukumar Nagendran

TSHA

Sukumar Nagendran serves as President and Head of R&D at Taysha Gene Therapies, Inc. (TSHA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$83.5K

Total Sells

5 trades

$3.99M

Net Position

Net Seller

$3.91M

Companies Traded

TSHA

Active Period

Feb 2022 – Jan 2026

7 total trades

Most Recent

Sell TSHA

Jan 23, 2026 · $547.5K

Sukumar Nagendran's Insider Trading at Taysha Gene Therapies, Inc. (TSHA)

Buys

2 · $83.5K

Sells

5 · $3.99M

Total Shares Bought

15,000

Total Shares Sold

943,276

TSHA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 23, 2026	Sell	116,050	$4.72	$547.5K	0
Jan 12, 2026	Sell	200,000	$4.71	$942.0K	0
Nov 28, 2025	Sell	370,172	$4.58	$1.70M	0
Sep 10, 2025	Sell	200,000	$3.23	$646.0K	0
Aug 21, 2025	Sell	57,054	$2.85	$162.6K	0
May 18, 2023	Buy	5,000	$0.68	$3.4K	34,226
Feb 3, 2022	Buy	10,000	$8.01	$80.1K	29,226

Related Insiders

Kamran Alam

CHIEF FINANCIAL OFFICER

TSHASell · Feb 4, 2026

Sean P. Nolan

Chief Executive Officer

TSHASell · Jan 23, 2026

Paul B Manning

10% Owner

TSHABuy · May 30, 2025

Explore More Insider Trading Data

TSHA Insider Trading Activity

View all insider trades at Taysha Gene Therapies, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity